The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
Mehdi Mirsaeidi(Jacksonville University), Nadera Sweiss(University of Illinois Chicago), Roberto F. Machado(University of Maryland, Baltimore), Robert P. Baughman(University of Cincinnati), Hesham R. Omar(Mercy Medical Center)
PubMed
December 23, 2016
Cited by 20
Related Papers
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis
|Critical Care Medicine|1997|863
ERS clinical practice guidelines on treatment of sarcoidosis
|European Respiratory Journal|2021|579
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
PD-1 up-regulation on CD4 <sup>+</sup> T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
|Science Translational Medicine|2018|364